| Dr. Falk Pharma AG - Jorveza 0.5 mg, Schmelztabletten | | 66999 | | 02 | | Jorveza 0.5 mg | | Schmelztabletten | | A07EA06 | | Budesonid | | 15.04.2021 | | |
| | Composition | | budesonidum 0.5 mg, dinatrii citras sesquihydricus, natrii dihydrogenocitras anhydricus, natrii hydrogenocarbonas, sucralosum, povidonum K 25, natrii docusas, mannitolum, macrogolum 6000, magnesii stearas pro compresso corresp. natrium 25.62 mg. | | Packungsbestandteile | | Schmeltabletten | | | | | Principe actif | Concentr. |
|---|
| Budesonide | 0.5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Budesonide | 0.5 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Dinatrii Citras Sesquihydricus | | | Macrogol | 6000 | | Magnesii Stearas pro Compresso | | | Mannitol | | | Natrii Dihydrogenocitras Anhydricus | | | Natrii Docusas | | | Sodium Hydrogenocarbonate | | | Povidonum K | 25 | | Sucralosum | |
| |
| |
|
